Jaafar, Sara
Lescoat, Alain
Huang, Suiyuan
Gordon, Jessica
Hinchcliff, Monique
Shah, Ami A.
Assassi, Shervin
Domsic, Robyn
Bernstein, Elana J.
Steen, Virginia
Elliott, Sabrina
Hant, Faye
Castelino, Flavia V.
Shanmugam, Victoria K.
Correia, Chase
Varga, John
Nagaraja, Vivek
Roofeh, David
Frech, Tracy
Khanna, Dinesh http://orcid.org/0000-0003-1412-4453
Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (K24-AR-063120, R01-AR070470-01A1)
Article History
Received: 8 January 2021
Accepted: 24 May 2021
First Online: 14 June 2021
Declarations
:
: All participants provided written consent to participate in this IRB-approved registry that started in April 2012.
: Not applicable
: SJ, AL, SH, MH, AS, SA, SE, FH, FC, VKS, CC, JV, VN, DR, and TF: nothing to disclose.JG reports grants from EICOS Sciences, grants from Cumberland Pharmaceuticals.RD reports personal fees from Formation Biologics, personal fees from Eicos Sciences, Inc, and personal fees from Corbus Pharmaceuticals.EB reports grants from NIH (K23 AR075112), grants and personal fees from Boehringer Ingleheim, grants and personal fees from Eicos Sciences, Inc, and grants from Pfizer.VS reports grants and others from Corbus; grants and others from Bayer; grants and others from CSL Behring; others from Forbius, during the conduct of the study; grants and others from Boehringer Ingelheim; grants and others from Eisocs; and grants from Reata.DK reports grants from NIH, grants from Immune Tolerance Network, grants and personal fees from Bayer, grants from Bristol Myers Squibb, grants from Horizon, grants from Pfizer, personal fees from Acceleron, personal fees from Actelion, personal fees from Amgen, personal fees from Blade Therapeutics, personal fees from Boehringer Ingelheim, personal fees from CSL Behring, personal fees from Corbus, personal fees from Cytori, personal fees from Galapagos, personal fees from Genentech/Roche, personal fees from GSK, personal fees from Horizon, personal fees from Merck, personal fees from Mitsubishi Tanabe Pharma, personal fees from Regeneron, personal fees from Sanofi-Aventis, personal fees from United Therapeutics, others from Impact PH, personal fees from Eicos Sciences, Inc, and personal fees and others from CiviBioPharma/Eicos Sciences, Inc.